End-Market ChallengesCertara continues to be a key player in the biosimulation space, but the end-market has not cooperated, seemingly affected by IRA concerns and a choppy funding environment.
Regulatory Services SegmentThe strategic evaluation of the regulatory services business is ongoing, indicating uncertainty in that segment.
Revenue PerformanceExpected revenue of $106.0 million came in below target, driven by lower-than-expected software sales.